Nuvectis Pharma Inc

NASDAQ:NVCT   11:54:04 AM EDT
15.94
+0.07 (+0.44%)
Earnings Announcements

Nuvectis Pharma Reports Fiscal Year 2021 Financial Results

Published: 03/22/2022 13:38 GMT
Nuvectis Pharma Inc (NVCT) - Nuvectis Pharma, Inc. Reports Fiscal Year 2021 Financial Results and Business Highlights.
Nuvectis Pharma Inc - Cash, Cash Equivalents and Short-term Investments Were $5.7 Million As of December 31, 2021.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.24

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.26

More details on our Analysts Page.